DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

30.14 0.39 (1.31%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SRPT $30.14 1.31%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $29.69
Previous Close $29.75
Daily Range $29.38 - $30.43
52-Week Range $11.33 - $33.16
Market Cap $1.2B
P/E Ratio -8.49
Dividend (Yield) $0.00 (0.0%)
Volume 663,607
Average Daily Volume 1,610,838
Current FY EPS -$4.92

Sector

Healthcare

Industry

Drug Makers

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sarepta.com/

News & Commentary Rss Feed

The Drug Development Process Explained in Detail and How It Impacts Your Investments

A detailed step-by-step guide on how a drug goes from a concept in the lab to a product on pharmacy shelves, and how the drug development process can affect your investments.

Several Biotech Stocks Indicating A Macro Short Strategy

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Pre

The Zacks Analyst Blog Highlights: Celgene, Juno Therapeutics, Intercept, BioMarin and Sarepta - Press Releases

Cramer Is Flying Southwest, Won't Recommend Sarepta Therapeutics

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Ana

Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog

Sarepta Therapeutics (SRPT) Showing Signs Of Perilous Reversal Today

Sarepta Files Eteplirsen NDA, Secures $40M Debt Financing - Analyst Blog

BioMarin's NDA for DMD Drug Drisapersen Accepted by FDA - Analyst Blog

5 Biotech Stocks On Deck With The FDA

Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT)

See More SRPT News...

SRPT's Top Competitors

SRPT $30.14 (1.31%)
Current stock: SRPT
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
BIIB $404.28 (-0.28%)
Current stock: BIIB